NHC National Healthcare Corp Forecast, Technical & Fundamental Analysis

NHC sees MACD Histogram just turned negative

NHC saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 25, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 41 instances where the indicator turned negative. In 27 of the 41 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 66%.

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 10-day moving average for NHC crossed bearishly below the 50-day moving average on September 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 53%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NHC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 11, 2026. You may want to consider a long position or call options on NHC as a result. In 65 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.

NHC moved above its 50-day moving average on September 09, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +3.93% 3-day Advance, the price is estimated to grow further. Considering data from situations where NHC advanced for three days, in 211 of 312 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 6 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.

The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.133) is normal, around the industry mean (238.721). P/E Ratio (25.221) is within average values for comparable stocks, (132.225). NHC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.624). Dividend Yield (0.012) settles around the average of (0.014) among similar stocks. P/S Ratio (2.269) is also within normal values, averaging (2.673).

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. NHC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 61 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.